You have 8 free searches left this month | for more free features.

Oral CGRP inhibitor

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Migraine Trial in United States (AXS-07 (meloxicam-rizatriptan))

Recruiting
  • Migraine
  • AXS-07 (meloxicam-rizatriptan)
  • Colton, California
  • +18 more
Sep 19, 2022

Migraine, Episodic Migraine, Headache Trial in New York (Click Digital Therapeutic)

Recruiting
  • Migraine
  • +3 more
  • Click Digital Therapeutic
  • New York, New York
    Click Therapeutics
Aug 15, 2023

Adenocarcinoma Esophagus, Locally Advanced Adenocarcinoma, Siewert Type I Adenocarcinoma of Esophagogastric Junction Trial

Not yet recruiting
  • Adenocarcinoma Esophagus
  • +3 more
  • (no location specified)
Sep 13, 2023

NSCLC Trial in Omaha (PLB1004)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Omaha, Nebraska
    Nebraska Cancer Specialists
Sep 19, 2023

Esophageal Achalasia Trial in Marseille, Montpellier, Nîmes (Protein pump inhibitor therapy systematically)

Recruiting
  • Esophageal Achalasia
  • Protein pump inhibitor therapy systematically
  • Marseille, France
  • +3 more
Jun 2, 2023

Breast Cancer, Breast Tumor, Breast Cancer Stage IV Trial in San Juan (MBQ-167)

Recruiting
  • Breast Cancer
  • +2 more
  • San Juan, Puerto Rico
    FDI Clinical Research
Oct 4, 2023

Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, Endometrial Cancer Trial in Oklahoma City, Houston (AO-252)

Recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Oklahoma City, Oklahoma
  • +1 more
Nov 13, 2023

Healthy Adults Trial in Dallas (Treatment A, Treatment B)

Not yet recruiting
  • Healthy Adults
  • Treatment A
  • Treatment B
  • Dallas, Texas
    Labcorp Clinical Research Unit Inc
May 11, 2023

Melanoma Metastatic in the Brain Trial in Gainesville (CA-4948, Pembrolizumab)

Not yet recruiting
  • Melanoma Metastatic in the Brain
  • Gainesville, Florida
    University of Florida
Dec 20, 2022

Sjogren's Syndrome Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (tofacitinib, Placebo)

Recruiting
  • Sjogren's Syndrome
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 24, 2022

Cholangiocarcinoma Metastatic Trial in China (TT-00420 (tinengotinib))

Not yet recruiting
  • Cholangiocarcinoma Metastatic
  • TT-00420 (tinengotinib)
  • Guangzhou, Guangdong, China
  • +6 more
Sep 26, 2023

Glucose Metabolism Disorders, Diabetes, Type 2, Hypoglycemic Agents Trial in Karachi (Empagliflozin 10 MG,

Recruiting
  • Glucose Metabolism Disorders
  • +3 more
  • Empagliflozin 10 MG
  • Insulin+Metformin+DPP4 inhibitor (DPP4I)
  • Karachi, Pakistan
    SINA Shireen Jinnah colony
Nov 28, 2023

Hypercholesterolaemia Trial (MK-0616)

Not yet recruiting
  • Hypercholesterolaemia
  • (no location specified)
Jul 12, 2023

Arteriosclerosis, Hypercholesterolaemia Trial (MK-0616, Placebo)

Not yet recruiting
  • Arteriosclerosis
  • Hypercholesterolaemia
  • (no location specified)
Aug 17, 2023

AORTIC VALVE DISEASES, Thromboembolism Trial in Korea, Republic of (Rivaroxaban Oral Tablet, Vitamin K antagonist(warfarin))

Recruiting
  • AORTIC VALVE DISEASES
  • Thromboembolism
  • Rivaroxaban Oral Tablet
  • Vitamin K antagonist(warfarin)
  • Bucheon, Korea, Republic of
  • +8 more
Oct 11, 2022

Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced

Completed
  • Oral Cancer
  • PD-1 inhibitor+carboplatin+albumin-bound paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital
Nov 20, 2023

Ovarian Cancer, Breast Cancer, Solid Tumor Trial in Houston, Brisbane (CYH33)

Recruiting
  • Ovarian Cancer
  • +4 more
  • New Haven, Connecticut
  • +6 more
Oct 10, 2022

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,

Not yet recruiting
  • Adenoid Cystic Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 14, 2023

Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)

Not yet recruiting
  • Hypercholesterolemia
  • Familial Hypercholesterolemia
  • (no location specified)
Jul 10, 2023

Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)

Not yet recruiting
  • Hypercholesterolemia
  • Familial Hypercholesterolemia
  • (no location specified)
Jul 10, 2023

Drug Drug Interaction Trial in Porto (Givinostat, Clarithromycin)

Completed
  • Drug Drug Interaction
  • Porto, Portugal
    Hospital da Prelada, 3rd Floor & East Wing 4th Floor Rua Sarment
Apr 26, 2023

Sudden Sensorineural Hearing Loss Trial (Statin, methylprednisolone, dexamethasone)

Not yet recruiting
  • Sudden Sensorineural Hearing Loss
  • (no location specified)
Feb 2, 2023

Coagulation Disorder Trial (PROTHROMPLEX TOTAL, 4F-PCC)

Not yet recruiting
  • Coagulation Disorder
  • (no location specified)
Jul 14, 2022

Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial (PHA-022121 low dose, PHA-022121 medium

Recruiting
  • Hereditary Angioedema
  • +11 more
  • PHA-022121 low dose
  • +3 more
  • Birmingham, Alabama
  • +7 more
Dec 5, 2022

Solid Tumors, Adult, Solid Tumor, Mesothelioma (MPM) Trial in United States (IK-930)

Recruiting
  • Solid Tumors, Adult
  • +7 more
  • Boston, Massachusetts
  • +6 more
Jan 24, 2023